This paper reports long-term results of RTOG 9903 , to determine whether the addition of erythropoietin ( EPO ) would improve the outcomes of radiation therapy ( RT ) in mildly to moderately anemic patients with head and neck squamous cell carcinoma ( HNSCCa ) .